Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer files US suit accusing Teva of falsely advertising generic Yaz

This article was originally published in Scrip

Executive Summary

Bayer Schering Pharma has filed yet another lawsuit pertaining to Teva Pharmaceutical Industries' recent US launch of a generic version of Yaz (drospirenone plus ethinyl estradiol) – this time accusing Teva of falsely claiming that its formulation and product contains the same product stabiliser as the branded Yaz product, and for infringing a Yaz patent pertaining to this stabiliser.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts